Friend or Foe? The Ambiguous Role of Innate Lymphoid Cells in Cancer Development

Munn, 2016, Immune suppressive mechanisms in the tumor microenvironment, Curr. Opin. Immunol., 39, 1, 10.1016/j.coi.2015.10.009 Sonnenberg, 2015, Innate lymphoid cells in the initiation, regulation and resolution of inflammation, Nat. Med., 21, 698, 10.1038/nm.3892 Spits, 2013, Innate lymphoid cells – a proposal for uniform nomenclature, Nat. Rev. Immunol., 13, 145, 10.1038/nri3365 von Burg, 2014, Activated group 3 innate lymphoid cells promote T-cell-mediated immune responses, Proc. Natl. Acad. Sci. U.S.A., 111, 12835, 10.1073/pnas.1406908111 Krysko, 2012, Immunogenic cell death and DAMPs in cancer therapy, Nature reviews. Cancer, 12, 860, 10.1038/nrc3380 Morvan, 2016, NK cells and cancer: you can teach innate cells new tricks, Nat. Rev. Cancer, 16, 7, 10.1038/nrc.2015.5 Fuchs, 2013, Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells, Immunity, 38, 769, 10.1016/j.immuni.2013.02.010 Bernink, 2013, Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues, Nat. Immunol., 14, 221, 10.1038/ni.2534 Klose, 2014, Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages, Cell, 157, 340, 10.1016/j.cell.2014.03.030 Dadi, 2016, Cancer immunosurveillance by tissue-resident innate lymphoid cells and innate-like T cells, Cell, 164, 365, 10.1016/j.cell.2016.01.002 Tugues, 2015, New insights into IL-12-mediated tumor suppression, Cell Death Differ., 22, 237, 10.1038/cdd.2014.134 Kodama, 1999, Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12, Eur. J. Immunol., 29, 1390, 10.1002/(SICI)1521-4141(199904)29:04<1390::AID-IMMU1390>3.0.CO;2-C Carnaud, 1999, Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells, J. Immunol., 163, 4647, 10.4049/jimmunol.163.9.4647 Eisenring, 2010, IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46, Nat. Immunol., 11, 1030, 10.1038/ni.1947 Zaidi, 2011, The two faces of interferon-gamma in cancer, Clin. Cancer Res., 17, 6118, 10.1158/1078-0432.CCR-11-0482 Bromberg, 1996, Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma, Proc. Natl. Acad. Sci. U.S.A., 93, 7673, 10.1073/pnas.93.15.7673 Beatty, 2001, IFN-gamma-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+ T cells requires tumor responsiveness to IFN-gamma, J. Immunol., 166, 2276, 10.4049/jimmunol.166.4.2276 Haabeth, 2011, Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer, Nat. Commun., 2, 240, 10.1038/ncomms1239 Hoepner, 2013, Synergy between CD8T cells and Th1 or Th2 polarised CD4T cells for adoptive immunotherapy of brain tumours, PloS ONE, 8, e63933, 10.1371/journal.pone.0063933 Whitmire, 2005, Interferon-gamma acts directly on CD8+ T cells to increase their abundance during virus infection, J. Exp. Med., 201, 1053, 10.1084/jem.20041463 Reiter, 1993, Interferon – a major regulator of natural killer cell-mediated cytotoxicity, J. Interferon Res., 13, 247, 10.1089/jir.1993.13.247 Martini, 2010, IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer, Vaccine, 28, 3548, 10.1016/j.vaccine.2010.03.007 Detjen, 2001, Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis, Gut, 49, 251, 10.1136/gut.49.2.251 Dighe, 1994, Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors, Immunity, 1, 447, 10.1016/1074-7613(94)90087-6 Vonarbourg, 2010, Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat+ innate lymphocytes, Immunity, 33, 736, 10.1016/j.immuni.2010.10.017 Waters, 2013, Tumour necrosis factor and cancer, J. Pathol., 230, 241, 10.1002/path.4188 Calzascia, 2007, TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice, J. Clin. Invest., 117, 3833 Dace, 2007, CD8+ T cells circumvent immune privilege in the eye and mediate intraocular tumor rejection by a TNF-alpha-dependent mechanism, J. Immunol., 178, 6115, 10.4049/jimmunol.178.10.6115 Kashii, 1999, Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells, J. Immunol., 163, 5358, 10.4049/jimmunol.163.10.5358 Prevost-Blondel, 2000, Crucial role of TNF-alpha in CD8T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo, J. Immunol., 164, 3645, 10.4049/jimmunol.164.7.3645 Wang, 2013, Epithelial–mesenchymal transition (EMT) induced by TNF-alpha requires AKT/GSK-3beta-mediated stabilization of snail in colorectal cancer, PloS ONE, 8, e56664, 10.1371/journal.pone.0056664 Balkwill, 2002, Tumor necrosis factor or tumor promoting factor?, Cytokine Growth Factor Rev., 13, 135, 10.1016/S1359-6101(01)00020-X Popivanova, 2008, Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis, J. Clin. Invest., 118, 560 Scott, 2003, An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors, Mol. Cancer Ther., 2, 445 Trabanelli, 2015, CD127+ innate lymphoid cells are dysregulated in treatment naive acute myeloid leukemia patients at diagnosis, Haematologica, 100, e257, 10.3324/haematol.2014.119602 Bernink, 2015, Interleukin-12 and -23 control plasticity of CD127+ group 1 and group 3 innate lymphoid cells in the intestinal lamina propria, Immunity, 43, 146, 10.1016/j.immuni.2015.06.019 Roediger, 2015, Group 2 innate lymphoid cells in the regulation of immune responses, Adv. Immunol., 125, 111, 10.1016/bs.ai.2014.09.004 Moro, 2010, Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells, Nature, 463, 540, 10.1038/nature08636 Molofsky, 2013, Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages, J. Exp. Med., 210, 535, 10.1084/jem.20121964 Nussbaum, 2013, Type 2 innate lymphoid cells control eosinophil homeostasis, Nature, 502, 245, 10.1038/nature12526 Bie, 2014, Polarization of ILC2s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer, J. Immunol. Res., 2014, 923135, 10.1155/2014/923135 Jovanovic, 2014, Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells, Int. J. Cancer, 134, 1669, 10.1002/ijc.28481 Mager, 2015, IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms, J. Clin. Invest., 125, 2579, 10.1172/JCI77347 Schwartz, 2016, Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer, Eur. J. Immunol., 46, 1091, 10.1002/eji.201545780 Gabitass, 2011, Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13, Cancer Immunol. Immunother., 60, 1419, 10.1007/s00262-011-1028-0 McHedlidze, 2013, Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis, Immunity, 39, 357, 10.1016/j.immuni.2013.07.018 Hams, 2014, IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis, Proc. Natl. Acad. Sci. U.S.A., 111, 367, 10.1073/pnas.1315854111 Hallett, 2012, Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13, Cancer Res., 72, 6338, 10.1158/0008-5472.CAN-12-3544 Li, 2014, Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation, J. Clin. Invest., 124, 3241, 10.1172/JCI73742 Noval Rivas, 2016, IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function, J. Allergy Clin. Immunol., 138, 801, 10.1016/j.jaci.2016.02.030 Pelly, 2016, IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection, Mucosal Immunol., 9, 1407, 10.1038/mi.2016.4 Ikutani, 2012, Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity, J. Immunol., 188, 703, 10.4049/jimmunol.1101270 Lotfi, 2007, Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors, J. Immunother., 30, 16, 10.1097/01.cji.0000211324.53396.f6 Schmitt, 2014, Th9 cells, new players in adaptive immunity, Trends Immunol., 35, 61, 10.1016/j.it.2013.10.004 Wilhelm, 2011, An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation, Nat. Immunol., 12, 1071, 10.1038/ni.2133 Purwar, 2012, Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells, Nat. Med., 18, 1248, 10.1038/nm.2856 Lu, 2012, Th9 cells promote antitumor immune responses in vivo, J. Clin. Invest., 122, 4160, 10.1172/JCI65459 Kim, 2015, Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells, Nat. Med., 21, 1010, 10.1038/nm.3922 Lange, 2003, Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice, Oncogene, 22, 517, 10.1038/sj.onc.1206076 Tomas, 2014, EGF receptor trafficking: consequences for signaling and cancer, Trends Cell Biol., 24, 26, 10.1016/j.tcb.2013.11.002 Monticelli, 2012, Innate lymphoid cells: critical regulators of allergic inflammation and tissue repair in the lung, Curr. Opin. Immunol., 24, 284, 10.1016/j.coi.2012.03.012 Busser, 2011, The multiple roles of amphiregulin in human cancer, Biochim. Biophys. Acta, 1816, 119 Zaiss, 2013, Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor, Immunity, 38, 275, 10.1016/j.immuni.2012.09.023 Salimi, 2016, Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production, J. Immunol., 196, 45, 10.4049/jimmunol.1501102 Cherrier, 2012, The development of LTi cells, Curr. Opin. Immunol., 24, 178, 10.1016/j.coi.2012.02.003 Klose, 2013, A T-bet gradient controls the fate and function of CCR6-RORgammat+ innate lymphoid cells, Nature, 494, 261, 10.1038/nature11813 Buonocore, 2010, Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology, Nature, 464, 1371, 10.1038/nature08949 Wang, 2015, The IL-23 to IL-17 cascade inflammation-related cancers, Clin. Exp. Rheumatol., 33, S87 Chan, 2014, Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells, Mucosal Immunol., 7, 842, 10.1038/mi.2013.101 Kirchberger, 2013, Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model, J. Exp. Med., 210, 917, 10.1084/jem.20122308 Huber, 2012, IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine, Nature, 491, 259, 10.1038/nature11535 Carrega, 2015, NCR+ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures, Nat. Commun., 6, 8280, 10.1038/ncomms9280 Moskalenko, 2015, Requirement for innate immunity and CD90+ NK1.1− lymphocytes to treat established melanoma with chemo-immunotherapy, Cancer Immunol. Res., 3, 296, 10.1158/2326-6066.CIR-14-0120 Cella, 2010, Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity, Proc. Natl. Acad. Sci. U.S.A., 107, 10961, 10.1073/pnas.1005641107 Hughes, 2010, Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue, Immunity, 32, 803, 10.1016/j.immuni.2010.06.007 Hughes, 2014, The transcription factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells, Cell Rep., 8, 150, 10.1016/j.celrep.2014.05.042 Jiang, 2011, Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3, Hepatology, 54, 900, 10.1002/hep.24486 Ohne, 2016, IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity, Nat. Immunol., 17, 646, 10.1038/ni.3447 Lim, 2016, IL-12 drives functional plasticity of human group 2 innate lymphoid cells, J. Exp. Med., 213, 569, 10.1084/jem.20151750 Pikovskaya, 2016, Eomesodermin is sufficient to direct type 1 innate lymphocyte development into the conventional NK lineage, J. Immunol., 196, 1449, 10.4049/jimmunol.1502396 Huang, 2015, IL-25-responsive, lineage-negative KLRG1hi cells are multipotential ‘inflammatory’ type 2 innate lymphoid cells, Nat. Immunol., 16, 161, 10.1038/ni.3078